AXIM Biotechnologies Completes Optimization of Only FDA-Cleared IgE Rapid Diagnostics Test – In-House Manufacturing Lowers Cost and Eliminates Supply Chain Expenditures
SAN DIEGO, May 24, 2022 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM”…
SAP Empowers Developers to Drive the Business AI Revolution
The All-American Koi Show 2026 – Experience the World’s Top Koi Exhibition in Las Vegas, NV
New GA-ASI Gambit 6 UCAV Adds Air-To-Ground Operations for International CCA
Military Metals Announces the Commencement of Resource Confirmation Drilling at the Flagship Trojarova Antimony Gold Project, European Union
FurGPT Invests in Kadena Chainweb EVM to Advance Decentralized AI Infrastructure